Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments

被引:131
|
作者
Hesslein, DGT
Pflugh, DL
Chowdhury, D
Bothwell, ALM
Sen, RJ
Schatz, DG
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
[4] Brandeis Univ, Rosenstiel Basic Med Res Ctr, Waltham, MA 02454 USA
[5] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA
关键词
V(D)J recombination; Pax5; accessibility; lymphocyte development; locus control;
D O I
10.1101/gad.1031403
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pax5-deficient progenitor B (pro-B) cells are thought to be severely defective for recombination of all immunoglobulin heavy chain (IgH) V gene segments, but the mechanism by which Pax5 regulates this process has not been defined. To address this issue, we have examined the assembly of the IgH locus in Pax5-deficient pro-B cells and find, unexpectedly, that 3' IgH V gene segments, which lie closest to the D-J-Cmu region, recombine efficiently, but progressively more distal V gene segments recombine progressively less efficiently. Histone acetylation and germ-line transcription correlate strongly with an open or an accessible chromatin structure thought to be permissive for V(D)J recombination, and defects in recombination are typically accompanied by deficits in these processes. We were therefore surprised to observe that distal V-H gene segments in Pax5-/- pro-B cells exhibit no defect in these measures of accessibility. The finding of transcribed, histone acetylated gene segments that fail to recombine suggests that a Pax5-dependent regulatory mechanism is required in addition to standard constraints of accessibility to control V-H gene recombination.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 50 条
  • [21] PAX5 expressions in hematologic malignancies
    Zhang, X
    Lin, Z
    Kim, I
    MODERN PATHOLOGY, 2003, 16 (01) : 261A - 261A
  • [22] DEREGULATED EXPRESSION OF PAX5 IN MEDULLOBLASTOMA
    KOZMIK, Z
    SURE, U
    RUEDI, D
    BUSSLINGER, M
    AGUZZI, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5709 - 5713
  • [23] Diagnostic uses of Pax5 immunohistochemistry
    Feldman, Andrew L.
    Dogan, Ahmet
    ADVANCES IN ANATOMIC PATHOLOGY, 2007, 14 (05) : 323 - 334
  • [24] Stepping up PAX5 expression
    Kirsty Minton
    Nature Reviews Immunology, 2009, 9 : 307 - 307
  • [25] Pax5 mediates the transcriptional activation of the CD81 gene
    Hosokawa, Kohei
    Ishimaru, Hanako
    Watanabe, Tadashi
    Fujimuro, Masahiro
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] One missense mutation in exon 2 of the PAX5 gene in Iran
    Yazdanparast, S.
    Khatami, S. R.
    Galehdari, H.
    Jaseb, K.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 17768 - 17775
  • [27] Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus
    Nutt, SL
    Urbanek, P
    Rolink, A
    Busslinger, M
    GENES & DEVELOPMENT, 1997, 11 (04) : 476 - 491
  • [28] The regulation of the B-cell gene expression programme by Pax5
    Holmes, Melissa L.
    Pridans, Clare
    Nutt, Stephen L.
    IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (01): : 47 - 53
  • [29] Pax5 mediates the transcriptional activation of the CD81 gene
    Kohei Hosokawa
    Hanako Ishimaru
    Tadashi Watanabe
    Masahiro Fujimuro
    Scientific Reports, 11
  • [30] Paired Box 5 (PAX5) Gene Has Diagnostic and Prognostic Potential in Nasopharyngeal Carcinoma
    Ye, Jiemei
    Huang, Xiaoying
    Qin, Weiling
    Liang, Pan
    Zhao, Jun
    Ye, Yinxin
    Ji, Huojin
    Peng, Xinyun
    Liang, Yushan
    Cai, Yonglin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 487 - 501